Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatocellular carcinoma: risk groups--screening].

K P Maier1

  • 1Medizinische Klinik, Fachbereich Gastroenterologie, Städtische Kliniken Esslingen, Akademisches Lehrkrankenhaus der Universität Tübingen. kp.maier@kliniken-es.de

Praxis
|September 18, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Iron, HCV and the liver.

World journal of gastroenterology·2016
Same author

[Are there therapeutic approaches of non-alcoholic fatty liver disease and its complications?].

Der Internist·2008
Same author

[Ascites].

Praxis·2008
Same author

[Non-alcoholic steatohepatitis--a new epidemic].

Praxis·2007
Same author

[Diverticulosis--diverticulitis].

Praxis·2007
Same author

[Non-alcoholic liver disease (NASH)].

Praxis·2006
Same journal

Praxis·2026
Same journal

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026
Same journal

[Laser interstitial thermotherapy (LITT): a minimally invasive neurosurgical treatment option for brain tumours and radiation necrosis].

Praxis·2026
Same journal

[Persistent back pain after lifting trauma. From the trivial to the rare case].

Praxis·2026
Same journal

[A patient with dizziness and gait instability - a diagnostic challenge].

Praxis·2026
Same journal

[Meningoencephalitis caused by listeria monocytogenes].

Praxis·2026
See all related articles

Liver cirrhosis is a premalignant condition with a 1-6% annual risk of hepatocellular carcinoma (HCC). Semi-annual screening with ultrasound and alpha-fetoprotein (AFP) is recommended for high-risk patients.

Area of Science:

  • Hepatology
  • Oncology
  • Gastroenterology

Context:

  • Liver cirrhosis, regardless of cause, is a significant premalignant condition.
  • Hepatocellular carcinoma (HCC) risk in cirrhotic patients ranges from 1% to 6% annually.
  • Current surveillance programs aim for early HCC detection to improve survival, but their efficacy requires controlled trials.

Purpose:

  • To evaluate the role of surveillance programs in early HCC detection.
  • To identify factors associated with high HCC risk in cirrhosis.
  • To provide interim recommendations for screening high-risk individuals.

Summary:

  • Cirrhosis presents a substantial risk for developing HCC.
  • Surveillance can detect small, potentially curable tumors.

Related Experiment Videos

  • Etiology, disease activity (transaminases, histology), Child-Pugh stage, and alpha-fetoprotein levels indicate high HCC risk.

    • Impact:

    • Surveillance programs can lead to earlier diagnosis and potentially curative treatment of HCC.
    • Identifying high-risk patients allows for targeted screening.
    • Further randomized controlled trials are needed to definitively establish surveillance efficacy.